262 Nitric oxide (NO) synthase oxygenase domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 8 | 5.3 | 1.50× | q = 0.19 | |
| Organometallic compounds | 2 | 0.0 | 129× | not tested | |
| Organosulfur compounds | 4 | 0.2 | 18× | not tested | |
| Organic nitrogen compounds | 5 | 0.4 | 14× | not tested | |
| Phenylpropanoids and polyketides | 2 | 0.2 | 8.87× | not tested | |
| Benzenoids | 7 | 0.8 | 8.83× | not tested | |
| Organoheterocyclic compounds | 9 | 1.7 | 5.39× | not tested | |
| Organic acids and derivatives | 8 | 1.7 | 4.77× | not tested | |
| Homogeneous non-metal compounds | 7 | 2.3 | 3.00× | not tested | |
| Organic oxygen compounds | 5 | 2.2 | 2.31× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 3.0 | 0.33× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB18267 | HEM | Ferroheme | 1,492 |
| DB00360 | H4B | Sapropterin | 1,327 |
| DB02994 | CAD | Cacodylic acid | 92 |
| DB00125 | ARG | Arginine | 65 |
| DB00742 | MTL | Mannitol | 23 |
| DB02234 | ITU | S-Ethylisothiourea | 23 |
| DB03144 | HAR | N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine | 23 |
| DB03175 | POL | Propyl alcohol | 22 |
| DB04400 | HBI | 7,8-dihydrobiopterin | 15 |
| DB02077 | DP9 | L-N(omega)-nitroarginine-(4R)-amino-L-proline amide | 14 |
| DB01997 | INE | 3-Bromo-7-Nitroindazole | 13 |
| DB01821 | DP1 | L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide | 12 |
| DB07388 | AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 11 |
| DB02562 | H2B | Quinonoid 7,8-Tetrahydrobiopterin | 9 |
| DB03317 | HEC | Ferroheme C | 9 |
| DB04223 | NRG | Nitroarginine | 9 |
| DB02044 | 14W | N-[3-(aminomethyl)benzyl]acetamidine | 8 |
| DB02207 | 7NI | 7-Nitroindazole | 8 |
| DB11588 | CMO | Carbon monoxide | 8 |
| DB02644 | 3AR | N-omega-propyl-L-arginine | 7 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 1,787 |
| ZNmetal | ZINC ION | 1,613 |
| H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 1,604 |
| CL | CHLORIDE ION | 444 |
| GDmetal | GADOLINIUM ATOM | 196 |
| CAD | CACODYLIC ACID | 91 |
| ARG | ARGININE | 66 |
| CAmetal | CALCIUM ION | 24 |
| MTL | D-MANNITOL | 23 |
| GD3metal | GADOLINIUM ION | 22 |
| HAR | N-OMEGA-HYDROXY-L-ARGININE | 22 |
| ITU | ETHYLISOTHIOUREA | 22 |
| POL | N-PROPANOL | 22 |
| NO | NITRIC OXIDE | 19 |
| KMI | 4-methyl-6-{3-[(methylamino)methyl]phenyl}pyridin-2-amine | 18 |
| XFJ | 6,6'-(pyridine-3,5-diyldiethane-2,1-diyl)bis(4-methylpyridin-2-amine) | 17 |
| XFN | 6,6'-[(5-aminobenzene-1,3-diyl)diethane-2,1-diyl]bis(4-methylpyridin-2-amine) | 17 |
| HBI | 7,8-DIHYDROBIOPTERIN | 14 |
| 8FD | 3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-[(2S)-2-(methylamino)propyl]benzonitrile | 12 |
| DP9 | L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE | 12 |